Articles From: CyberOptics Fourth Quarter 2014 Conference Call Scheduled for February 18 to Cypress and Arrow Electronics Announce Internet of Things Design Contest


2015/2/5
CyberOptics Corporation (Nasdaq: CYBE) will hold its conference call to review operating results for the fourth quarter of 2014 on Wednesday, February 18 at 4:30 PM Eastern.
Sign-up for CyberOptics Fourth Quarter 2014 Conference Call Scheduled for February 18 investment picks
2015/2/17
CyberOptics Corporation (Nasdaq: CYBE) will hold its conference call to review operating results for the fourth quarter of 2014 on Wednesday, February 18 at 4:30 PM Eastern.
Sign-up for CyberOptics Fourth Quarter 2014 Conference Call Scheduled for February 18 investment picks
2015/2/24
CyberOptics® Corporation (NASDAQ: CYBE), a leading global developer and manufacturer of high precision 3D sensing technology solutions, will present at the SPIE Advanced Lithography 2015, the industry's most important event for lithography R&D, devices, tools, fabrication, and services, at the San Jose Marriott and San Jose Convention Center today.
Sign-up for CyberOptics Presents Best Practice Process Insights for Reticle Environments at SPIE Advanced Lithography 2015 investment picks
2015/2/18
CyberOptics Corporation (Nasdaq: CYBE) today reported significantly improved operating results for the fourth quarter of 2014 ended December 31, 2014 compared to the quarter ended December 31, 2013.
Sign-up for CyberOptics Reports Profitable, Double-Digit Growth in Fourth Quarter of 2014 investment picks
2015/2/4
CyberOptics® Corporation (Nasdaq: CYBE), a leading global developer and manufacturer of high precision 3D sensing technology solutions, announces that it will demonstrate the new SQ3000™ 3D Automated Optical Inspection (AOI) system in Booth #3332 at the IPC APEX EXPO , Feb.
Sign-up for CyberOptics to Demonstrate the New SQ3000 3D AOI With Multi-Reflection Suppression Technology Inside investment picks
2015/2/9
Cybersecurity Concerns Rise as a Risk Factor for Board Members and Senior Executives in 2015 Global survey report from Protiviti and North Carolina State University's ERM Initiative identifies top macroeconomic, strategic and operational risks for businesses Canada NewsWire MENLO PARK, Calif.
Sign-up for Cybersecurity Concerns Rise as a Risk Factor for Board Members and Senior Executives in 2015 investment picks
2015/2/9
Global survey report from Protiviti and North Carolina State University's ERM Initiative identifies top macroeconomic, strategic and operational risks for businesses MENLO PARK, Calif.
Sign-up for Cybersecurity Concerns Rise as a Risk Factor for Board Members and Senior Executives in 2015 investment picks
2015/2/13
STANFORD, Calif.--President Barack Obama and top aides urged businesses to share more information about computer breaches, while corporate executives pleaded with government agencies to share intelligence, as both sides search for answers to stem the rise of cyberattacks.
Sign-up for Cybersecurity Summit Exposes Silicon Valley's Privacy Fears investment picks
2015/2/26
Cyc Fitness today announced an incubator investment from The Hain Celestial Group, Inc .
Sign-up for Cyc Fitness Announces Incubator Investment from The Hain Celestial Group, Inc. investment picks
2014/12/16
- DSMB determined that the planned futility boundary has been crossed; but saw no reason for patients to discontinue from study - BERKELEY HEIGHTS, N.J., Dec.
Sign-up for Cyclacel Announces Enrollment of 486 Patients, DSMB Recommendations and That the Seamless Phase 3 Trial of Sapacitabine in AML Will Continue to Final Analysis investment picks
2015/2/3
BERKELEY HEIGHTS, N.J., Feb.
Sign-up for Cyclacel Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/1/6
BERKELEY HEIGHTS, N.J., Jan.
Sign-up for Cyclacel Pharmaceuticals to Present at the Biotech Showcase(TM) 2015 Conference investment picks
2015/2/19
BRISBANE, Australia--Thousands of Australians were bracing for severe flooding and emergency workers evacuated some small coastal towns Friday as two powerful tropical storms swept across northern areas in a rare weather assault that officials said threatened to trigger a "calamity". The twin storms, Cyclone Lam and Cyclone Marcia, barreled inland on Friday over areas 1,500 miles apart, hitting the outback Northern Territory and the more populated central coast of Queensland state, knocking out power in some areas and cutting road access.
Sign-up for Cyclones Marcia and Lam Barrel into Australia investment picks
2015/1/12
http://www.marketwire.com/library/MwGo/2015/1/11/11G030102/Logo1-1973187467.jpg NEWARK, CA--(Marketwired - January 12, 2015) - CymaBay Therapeutics Inc. (NASDAQ: CBAY) today announced positive preliminary results from its clinical study of arhalofenate administered in combination with febuxostat (Uloric™, Takeda Pharmaceutical Company Limited). Arhalofenate is a once-daily, oral candidate for the treatment of gout with a unique dual mechanism of action which lowers serum uric acid (sUA) while also reducing the occurrence of gout flares.
Sign-up for Cymabay Therapeutics Announces Positive Results From Its Phase 2 Clinical Study of Arhalofenate in Combination With Febuxostat investment picks
2015/2/24
http://www.marketwire.com/library/MwGo/2015/2/24/11G033927/Logo1-1296114052.jpg NEWARK, CA--(Marketwired - February 24, 2015) - CymaBay Therapeutics, Inc. (NASDAQ: CBAY) today announced positive preliminary topline results from its Phase 2b clinical study of its lead product candidate, arhalofenate, for the treatment of gout.
Sign-up for CymaBay Therapeutics Announces Positive Results From Its Phase 2b Clinical Study Demonstrating That Arhalofenate Met the Primary Endpoint of Reduction in Gout Flares investment picks
2015/1/28
http://www.marketwire.com/library/MwGo/2015/1/28/11G031610/Logo1-445926415.jpg http://www.marketwire.com/library/MwGo/2015/1/28/11G031610/Images/WHHLRabbitModel-405471649313.jpg WHHL Rabbit Model NEWARK, CA--(Marketwired - January 28, 2015) - CymaBay Therapeutics (NASDAQ: CBAY) today announced results from a preclinical study indicating the potential for MBX-8025 to decrease low-density lipoprotein cholesterol (LDL-C) in patients with homozygous familial hypercholesterolemia (HoFH). MBX-8025 is a potent and selective peroxisome proliferator-activated receptor delta (PPARδ) agonist that, in previous clinical studies, has been shown to reduce LDL-C in patients with mixed dyslipidemia.
Sign-up for CymaBay Therapeutics Announces Preclinical Data Demonstrating the Potential of MBX-8025 to Treat Homozygous Familial Hypercholesterolemia investment picks
2015/2/4
http://www.marketwire.com/library/MwGo/2015/2/4/11G032299/Logo1-948842727.jpg NEWARK, CA--(Marketwired - February 04, 2015) - CymaBay Therapeutics Inc. (NASDAQ: CBAY) announced today that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 17th Annual BIO CEO & Investor Conference on Monday, February 9 at 2:30 p.m. Eastern Time.
Sign-up for CymaBay to Present at 17th Annual BIO CEO & Investor Conference investment picks
2015/2/27
http://www.marketwire.com/library/MwGo/2015/2/27/11G034372/Logo1-1300249686.jpg NEWARK, CA--(Marketwired - February 27, 2015) - CymaBay Therapeutics, Inc. (NASDAQ: CBAY) announced today that members of its senior management team are scheduled to present at three upcoming investor conferences detailed below.
Sign-up for CymaBay to Present at Upcoming Investor Conferences investment picks
2015/1/15
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF) , a specialty pharmaceutical company, today announced that its President and CEO, Anthony Giovinazzo, will present at the Noble Financial Capital Markets’ Eleventh Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Monday, January 19 th at 10:00am Eastern Standard Time in Room 1.
Sign-up for Cynapsus Therapeutics Inc. to Present at the D2 2015 - Noble Financial Capital Markets' Eleventh Annual Investor / Equity Conference investment picks
2015/2/24
New System Slated for Introduction at American Academy of Dermatology 2015 Annual Meeting WESTFORD, Mass.
Sign-up for Cynosure Announces FDA Clearance of New 532 nm Laser Delivery System for PicoSure® investment picks
2015/1/13
WESTFORD, Mass.
Sign-up for Cynosure Appoints William O. Flannery as Lead Director investment picks
2014/12/3
Statistically Significant Improvement Shown in Vaginal Health of Postmenopausal Women WESTFORD, Mass.
Sign-up for Cynosure Discusses Favorable Clinical Data from Trial of MonaLisa Touch™ Laser Treatment investment picks
2015/2/10
WESTFORD, Mass.
Sign-up for Cynosure Reports Record Quarterly Revenue of $86.3 Million for the Fourth Quarter of 2014 investment picks
2015/1/26
WESTFORD, Mass.
Sign-up for Cynosure To Host Fourth-Quarter 2014 Financial Results Conference Call On February 10 investment picks
2015/2/9
Fireside Chat to be Webcast Live at 11:10 a.m. (ET) Thursday, February 12 WESTFORD, Mass.
Sign-up for Cynosure to Participate in Leerink Global Healthcare Conference investment picks
2014/12/29
Presentation to be Webcast Live at 8:00 a.m. (ET) Tuesday, January 13, 2015 WESTFORD, Mass.
Sign-up for Cynosure to Present at 17th Annual Needham Growth Conference investment picks
2014/12/11
Regulatory News: Hexcel Corporation (NYSE:HXL) (Paris:HXL) today announced that Ms.
Sign-up for Cynthia Egnotovich Named to Hexcel Corporation’s Board of Directors investment picks
2015/1/22
Sequenom to apply Cypher's Mantis technology for advanced genome interpretation in NIPT SAN DIEGO , Jan.
Sign-up for Cypher Genomics and Sequenom Announce Development Agreement investment picks
2015/2/27
Companies to demonstrate Cypher's unique voice isolation algorithm based on neural network analysis of human speech running on CEVA-TeakLite-4 audio/voice DSP at Mobile World Congress 2015 MOUNTAIN VIEW, Calif.
Sign-up for Cypher Partners with CEVA to Offer Innovative Noise Reduction Solution for Mobile, Wearables and Voice-activated Devices investment picks
2015/2/19
http://media.marketwire.com/attachments/201402/222796_CY_CAP_LOGO3.jpg http://media.marketwire.com/attachments/201502/84263_video2.gif This video provides a demonstration of the easy-to-use PSoC 4 Bluetooth Low Energy Pioneer Kit from Cypress, which is ideal for Internet of Things designs.
Sign-up for Cypress and Arrow Electronics Announce Internet of Things Design Contest investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: CyberOptics Fourth Quarter 2014 Conference Call Scheduled for February 18 to Cypress and Arrow Electronics Announce Internet of Things Design Contest
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent